Concord Wealth Partners - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$98,066
-25.9%
15,275
-14.1%
0.02%
-44.7%
Q1 2023$132,424
+70.5%
17,7750.0%0.04%
+65.2%
Q4 2022$77,677
-22.3%
17,7750.0%0.02%
-28.1%
Q3 2022$100,000
-2.9%
17,7750.0%0.03%
+14.3%
Q2 2022$103,000
-39.4%
17,775
+6.0%
0.03%
-36.4%
Q1 2022$170,000
+60.4%
16,775
+31.3%
0.04%
+69.2%
Q4 2021$106,00012,7750.03%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders